Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| MIDAZOLAM INJECTION | PFIZER CANADA ULC | Actual shortage | 1MG | Updated Report | 2019-09-21 | 82597 |
| PRO-SOTALOL | PRO DOC LIMITEE | Actual shortage | 80MG | Updated Report | 2019-09-21 | 91654 |
| PRECEDEX | PFIZER CANADA ULC | Actual shortage | 4MCG | Updated Report | 2019-09-21 | 93225 |
| POTASSIUM CHLORIDE INJECTION | BAXTER CORPORATION | Actual shortage | 14.9MG | Updated Report | 2019-09-21 | 94470 |
| APO-GLIMEPIRIDE | APOTEX INC | Resolved | 4MG | Updated Report | 2019-09-21 | 31007 |
| APO-GLIMEPIRIDE | APOTEX INC | Resolved | 1MG | Updated Report | 2019-09-21 | 32536 |
| APO-GLIMEPIRIDE | APOTEX INC | Resolved | 2MG | Updated Report | 2019-09-21 | 55281 |
| FML 0.1% | ALLERGAN INC | Resolved | 0.1% | Updated Report | 2019-09-21 | 91579 |
| METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Actual shortage | 25MG | Updated Report | 2019-09-21 | 93692 |
| LOCACORTEN VIOFORM EARDROPS | PALADIN LABS INC | Actual shortage | 0.02% 1% | Updated Report | 2019-09-21 | 94432 |
| 5% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 5G | Updated Report | 2019-09-21 | 94473 |
| POTASSIUM CHLORIDE INJECTION | BAXTER CORPORATION | Actual shortage | 7.46MG | Updated Report | 2019-09-20 | 89426 |
| APO-RIVASTIGMINE | APOTEX INC | Actual shortage | 1.5MG | Updated Report | 2019-09-20 | 20900 |
| APO-RIVASTIGMINE | APOTEX INC | Actual shortage | 4.5MG | Updated Report | 2019-09-20 | 85610 |
| APO-RIVASTIGMINE | APOTEX INC | Actual shortage | 3MG | Updated Report | 2019-09-20 | 86336 |
| APO-RIVASTIGMINE | APOTEX INC | Actual shortage | 6MG | Updated Report | 2019-09-20 | 88360 |
| GENOTROPIN | PFIZER CANADA ULC | Actual shortage | 1.4MG | Updated Report | 2019-09-20 | 93856 |
| NOLVADEX-D TAB 20MG | ASTRAZENECA CANADA INC | Anticipated shortage | 20MG | Updated Report | 2019-09-20 | 94235 |
| RANITIDINE - 150 | PRO DOC LIMITEE | Actual shortage | 150MG | Updated Report | 2019-09-20 | 94391 |
| RANITIDINE - 300 | PRO DOC LIMITEE | Actual shortage | 300MG | Updated Report | 2019-09-20 | 94394 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-09-20 | 94411 |
| OLMETEC PLUS | MERCK CANADA INC | Actual shortage | 12.5MG 20MG | Updated Report | 2019-09-19 | 90616 |
| PREVYMIS | MERCK CANADA INC | Anticipated shortage | 20MG | Updated Report | 2019-09-19 | 92759 |
| SODIUM THIOSULFATE INJECTION USP | HOPE PHARMACEUTICALS LTD | Anticipated shortage | 250MG | Updated Report | 2019-09-19 | 94406 |
| PROQUAD | MERCK CANADA INC | Avoided shortage | 4.30Log10 TCID50 3.99Log10 PFU 3.00Log10 TCID50 3.00Log10 TCID50 | Updated Report | 2019-09-19 | 90641 |
| MYLAN-TADALAFIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 20MG | New Report | 2019-09-19 | 94402 |
| GONAL-F PEN | EMD SERONO A DIVISION OF EMD INC CANADA | Anticipated shortage | 300UNIT | Updated Report | 2019-09-19 | 94397 |
| DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML | PFIZER CANADA ULC | Actual shortage | 150MG | Updated Report | 2019-09-19 | 88645 |
| BREVICON 1/35 TABLETS (28-DAY PACK) | PFIZER CANADA ULC | Actual shortage | 0.035MG 1MG | Updated Report | 2019-09-19 | 92052 |
| ACT QUETIAPINE | ACTAVIS PHARMA COMPANY | Actual shortage | 25MG | New Report | 2019-09-19 | 94384 |
| TEVA-TAMOXIFEN | TEVA CANADA LIMITED | Actual shortage | 20MG | New Report | 2019-09-19 | 94381 |
| TEVA-CAPTOPRIL | TEVA CANADA LIMITED | Actual shortage | 100MG | New Report | 2019-09-19 | 94378 |
| TEVA-QUETIAPINE XR | TEVA CANADA LIMITED | Actual shortage | 400MG | New Report | 2019-09-19 | 94375 |
| TEVA-ATORVASTATIN | TEVA CANADA LIMITED | Actual shortage | 80MG | New Report | 2019-09-19 | 94372 |
| TEVA-IRBESARTAN | TEVA CANADA LIMITED | Actual shortage | 150MG | New Report | 2019-09-19 | 94369 |
| TEVA-ROSUVASTATIN | TEVA CANADA LIMITED | Resolved | 40MG | Updated Report | 2019-09-19 | 92157 |
| TEVA-RIZATRIPTAN ODT | TEVA CANADA LIMITED | Resolved | 5MG | Updated Report | 2019-09-19 | 92151 |
| NOVO-GESIC | TEVA CANADA LIMITED | Actual shortage | 325MG | Updated Report | 2019-09-19 | 87680 |
| AMPICILLIN SODIUM FOR INJECTION, USP | TEVA CANADA LIMITED | Resolved | 250MG | Updated Report | 2019-09-19 | 93110 |
| AMPICILLIN SODIUM FOR INJECTION, USP | TEVA CANADA LIMITED | Resolved | 2000MG | Updated Report | 2019-09-19 | 86942 |
| AMPICILLIN SODIUM FOR INJECTION, USP | TEVA CANADA LIMITED | Resolved | 1000MG | Updated Report | 2019-09-19 | 86939 |
| ACT RIZATRIPTAN | ACTAVIS PHARMA COMPANY | Actual shortage | 10MG | Updated Report | 2019-09-19 | 93169 |
| ACT BUPROPION XL | ACTAVIS PHARMA COMPANY | Actual shortage | 300MG | Updated Report | 2019-09-19 | 68580 |
| ACT BUPROPION XL | ACTAVIS PHARMA COMPANY | Actual shortage | 300MG | Updated Report | 2019-09-19 | 68577 |
| ACT BUPROPION XL | ACTAVIS PHARMA COMPANY | Actual shortage | 150MG | Updated Report | 2019-09-19 | 68569 |
| TEVA-QUETIAPINE XR | TEVA CANADA LIMITED | Actual shortage | 300MG | Updated Report | 2019-09-19 | 93656 |
| TEVA-SOLIFENACIN | TEVA CANADA LIMITED | Actual shortage | 5MG | Updated Report | 2019-09-19 | 93149 |
| TEVA-MODAFINIL | TEVA CANADA LIMITED | Actual shortage | 100MG | Updated Report | 2019-09-19 | 93137 |
| TEVA-SUCRALFATE | TEVA CANADA LIMITED | Actual shortage | 1G | Updated Report | 2019-09-19 | 92663 |
| VINBLASTINE SULPHATE INJECTION | TEVA CANADA LIMITED | Actual shortage | 1MG | Updated Report | 2019-09-19 | 92198 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| APO-SOLIFENACIN | APOTEX INC | Discontinued | 10MG | Updated Report | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | APOTEX INC | Discontinued | 5MG | Updated Report | 2019-09-20 | 78272 |
| APO-GLIMEPIRIDE | APOTEX INC | Discontinued | New Report | 2019-09-20 | 94452 | |
| APO-GLIMEPIRIDE | APOTEX INC | Discontinued | New Report | 2019-09-20 | 94449 | |
| APO-GLIMEPIRIDE | APOTEX INC | Discontinued | New Report | 2019-09-20 | 94446 | |
| RETROVIR (AZT) | VIIV HEALTHCARE ULC | To be discontinued | 100MG | New Report | 2019-09-18 | 94281 |
| TRIZIVIR | VIIV HEALTHCARE ULC | Discontinued | 300MG 300MG 150MG | New Report | 2019-09-18 | 94278 |
| VALSARTAN HCT | SIVEM PHARMACEUTICALS ULC | To be discontinued | 25MG 320MG | New Report | 2019-09-18 | 94211 |
| BICALUTAMIDE | SIVEM PHARMACEUTICALS ULC | To be discontinued | 50MG | Updated Report | 2019-09-18 | 86431 |
| BICALUTAMIDE | SIVEM PHARMACEUTICALS ULC | To be discontinued | 50MG | Updated Report | 2019-09-18 | 86436 |
